Home > Clinical Research > Regulatory affairs
Regulatory affairs PDF Print E-mail

Bringing a new product from its development to marketing approval is an expensive and lengthy process. If unanticipated delays occur, costs in both time and money can rapidly escalate.The staffs at G7 Synergon are well experienced to support clients throughout the entire drug development program, from early consultations to clinical trials and marketing authorisation submissions. Our experience in handling a wide variety of regulatory challenges helps the client to meet exigent timelines. We have the ability to provide regulatory services as a complete study management and/or as customized services.

Clinical Regulatory services include:

• Preparation and submission of clinical trial applications (CTA)
• Local accompanying of the approval process and communication with regulatory authorities
• Clinical Trial Registry Entry (CTRI)
• Import /Export Licenses
• T - License procurement
• Approval from Genetic Engineering Approval Committee (GEAC) for Biotech products

Pharma Regulatory services include:

• Dossier Development and submission (CTD and e-CTD)
• DMF preparation
• Conversion review of old dossiers from general format to CTD format
• CMC documentations and submissions
• Variation filings

 

News

Post Marketing Clinical (PMC)

Phase IV Studies – A Market With A Proactive Approach For Growth Of A Pharmaceutical Busine...

CHRONICLE PHARMABIZ

India, an emerging global hub for vaccine industry ASIA is emerging as the vaccine hub ...

Vaccine Industry in India – An Emerging Global Hub

Asia is emerging as the vaccine hub of the world and India is on the go to play a key role in the...

RECOGNITIONS

“G7 SYNERGON has been recognized by the Department of Scientific and Industrial Research (D...

G7 Group Companies

News Letter

Counter :mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
© 2010 G7 SYNERGON. All rights Reserved